These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 11595395

  • 1. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.
    Auer DP, Wilke M, Grabner A, Heidenreich JO, Bronisch T, Wetter TC.
    Schizophr Res; 2001 Oct 01; 52(1-2):87-99. PubMed ID: 11595395
    [Abstract] [Full Text] [Related]

  • 2. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
    Sigmundsson T, Maier M, Toone BK, Williams SC, Simmons A, Greenwood K, Ron MA.
    Schizophr Res; 2003 Nov 01; 64(1):63-71. PubMed ID: 14511802
    [Abstract] [Full Text] [Related]

  • 3. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR.
    Neuroimage; 2004 Apr 01; 21(4):1781-9. PubMed ID: 15050598
    [Abstract] [Full Text] [Related]

  • 4. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct 01; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 5. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.
    Fukuzako H, Takeuchi K, Hokazono Y, Fukuzako T, Yamada K, Hashiguchi T, Obo Y, Ueyama K, Takigawa M, Fujimoto T.
    Psychiatry Res; 1995 Nov 10; 61(4):193-200. PubMed ID: 8748464
    [Abstract] [Full Text] [Related]

  • 6. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J, Al-Semaan Y, Drost DJ, Malla AK, Neufeld RW, Bartha R, Manchanda R, Menon R, Densmore M, Schaefer B, Williamson PC.
    Psychiatry Res; 2004 Jul 30; 131(2):107-14. PubMed ID: 15313517
    [Abstract] [Full Text] [Related]

  • 7. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
    Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA, HIV MRS Consortium.
    Neuroimage; 2004 Dec 30; 23(4):1336-47. PubMed ID: 15589098
    [Abstract] [Full Text] [Related]

  • 8. Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy.
    Omori M, Murata T, Kimura H, Koshimoto Y, Kado H, Ishimori Y, Ito H, Wada Y.
    Psychiatry Res; 2000 May 15; 98(3):155-62. PubMed ID: 10821998
    [Abstract] [Full Text] [Related]

  • 9. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
    Zhu X, Schuff N, Kornak J, Soher B, Yaffe K, Kramer JH, Ezekiel F, Miller BL, Jagust WJ, Weiner MW.
    Alzheimer Dis Assoc Disord; 2006 May 15; 20(2):77-85. PubMed ID: 16772742
    [Abstract] [Full Text] [Related]

  • 10. N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI.
    Jakary A, Vinogradov S, Feiwell R, Deicken RF.
    Schizophr Res; 2005 Jul 15; 76(2-3):173-85. PubMed ID: 15949650
    [Abstract] [Full Text] [Related]

  • 11. MRS shows syndrome differentiated metabolite changes in human-generalized epilepsies.
    Savic I, Osterman Y, Helms G.
    Neuroimage; 2004 Jan 15; 21(1):163-72. PubMed ID: 14741653
    [Abstract] [Full Text] [Related]

  • 12. Replicability of proton MR spectroscopic imaging findings in mild traumatic brain injury: Implications for clinical applications.
    Chen AM, Gerhalter T, Dehkharghani S, Peralta R, Gajdošík M, Gajdošík M, Tordjman M, Zabludovsky J, Sheriff S, Ahn S, Babb JS, Bushnik T, Zarate A, Silver JM, Im BS, Wall SP, Madelin G, Kirov II.
    Neuroimage Clin; 2023 Jan 15; 37():103325. PubMed ID: 36724732
    [Abstract] [Full Text] [Related]

  • 13. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.
    Psychiatry Res; 2004 Jul 30; 131(2):95-105. PubMed ID: 15313516
    [Abstract] [Full Text] [Related]

  • 14. Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study.
    Auer DP, Schirmer T, Heidenreich JO, Herzog J, Pütz B, Dichgans M.
    Neurology; 2001 Mar 13; 56(5):635-42. PubMed ID: 11245716
    [Abstract] [Full Text] [Related]

  • 15. Subtype-associated metabolite differences in the temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy.
    Fukuzako H, Kodama S, Fukuzako T, Yamada K, Doi W, Sato D, Takigawa M.
    Psychiatry Res; 1999 Nov 08; 92(1):45-56. PubMed ID: 10688159
    [Abstract] [Full Text] [Related]

  • 16. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
    Cohen RA, Harezlak J, Gongvatana A, Buchthal S, Schifitto G, Clark U, Paul R, Taylor M, Thompson P, Tate D, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B, HIV Neuroimaging Consortium.
    J Neurovirol; 2010 Nov 08; 16(6):435-44. PubMed ID: 20961212
    [Abstract] [Full Text] [Related]

  • 17. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T.
    Psychiatry Clin Neurosci; 2006 Jun 08; 60(3):365-72. PubMed ID: 16732755
    [Abstract] [Full Text] [Related]

  • 18. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.
    Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A.
    Arch Gen Psychiatry; 1998 Apr 08; 55(4):346-52. PubMed ID: 9554430
    [Abstract] [Full Text] [Related]

  • 19. Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability.
    Wiedermann D, Schuff N, Matson GB, Soher BJ, Du AT, Maudsley AA, Weiner MW.
    Magn Reson Imaging; 2001 Oct 08; 19(8):1073-80. PubMed ID: 11711231
    [Abstract] [Full Text] [Related]

  • 20. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
    Sijens PE, Mostert JP, Oudkerk M, De Keyser J.
    Eur Radiol; 2006 Feb 08; 16(2):489-95. PubMed ID: 16028056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.